Currently predicting for Thu, 4 Jun 2026

ABBV Prediction Chart

ABBV Predictions History

Latest community submissions for ABBV.
Predictor Target Session Target Price Result Direction Accuracy Score
Sep 24, 2025 $222.61 +0.00% $219.99 V 98.81% 2
Aug 4, 2025 $193.28 -0.99% $197.19 X 98.02% 0
Aug 4, 2025 $194.01 -0.62% $197.19 X 98.39% 0
Aug 4, 2025 Bullish $197.19 V 1
Jun 16, 2025 $189.37 -0.90% $190.86 V 99.22% 3
Jun 16, 2025 $190.01 -0.56% $190.86 V 99.55% 5
Jun 16, 2025 $191.08 +0.00% $190.86 V 99.88% 6
May 19, 2025 $186.66 +1.43% $185.71 V 99.49% 4
May 19, 2025 $185.67 +0.90% $185.71 V 99.98% 10
May 19, 2025 Bullish $185.71 V 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ABBV with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ABBVIE INC
AbbVie
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia ...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE